Scientific article
OA Policy
English

Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis

Published inThe Lancet Global Health, vol. 5, no. 4, p. e439-e447
Publication date2017
Abstract

Chagas disease is currently prevalent in European countries hosting large communities from Latin America. Whether asymptomatic individuals at risk of Chagas disease living in Europe should be screened and treated accordingly is unclear. We performed an economic evaluation of systematic Chagas disease screening of the Latin American population attending primary care centres in Europe.

Keywords
  • Antiprotozoal Agents/economics
  • Chagas Disease/diagnosis/economics/ethnology
  • Cost-Benefit Analysis
  • Emigrants and Immigrants/statistics & numerical data
  • Europe/epidemiology
  • Female
  • Humans
  • Latin America/ethnology
  • Male
  • Mass Screening/economics/statistics & numerical data
  • Primary Health Care/economics/organization & administration
Citation (ISO format)
REQUENA-MÉNDEZ, Ana et al. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. In: The Lancet Global Health, 2017, vol. 5, n° 4, p. e439–e447. doi: 10.1016/S2214-109X(17)30073-6
Main files (1)
Article (Published version)
Identifiers
Journal ISSN2214-109X
879views
255downloads

Technical informations

Creation02/20/2018 2:16:00 PM
First validation02/20/2018 2:16:00 PM
Update time03/15/2023 7:53:18 AM
Status update03/15/2023 7:53:17 AM
Last indexation10/31/2024 9:39:37 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack